Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Purchased by Corrado Advisors LLC

Corrado Advisors LLC raised its position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) by 17.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,323 shares of the company’s stock after acquiring an additional 11,099 shares during the quarter. Corrado Advisors LLC owned approximately 1.08% of Global X Genomics & Biotechnology ETF worth $731,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Atria Investments Inc purchased a new stake in Global X Genomics & Biotechnology ETF during the 3rd quarter worth approximately $122,000. Rockefeller Capital Management L.P. acquired a new position in shares of Global X Genomics & Biotechnology ETF in the third quarter worth $205,000. Oxinas Partners Wealth Management LLC purchased a new stake in shares of Global X Genomics & Biotechnology ETF during the fourth quarter worth $103,000. Insight Advisors LLC PA boosted its holdings in Global X Genomics & Biotechnology ETF by 20.4% in the fourth quarter. Insight Advisors LLC PA now owns 29,192 shares of the company’s stock valued at $282,000 after purchasing an additional 4,942 shares during the period. Finally, McGuire Investment Group LLC boosted its holdings in Global X Genomics & Biotechnology ETF by 3.5% in the fourth quarter. McGuire Investment Group LLC now owns 58,109 shares of the company’s stock valued at $564,000 after purchasing an additional 1,940 shares during the period. 56.95% of the stock is currently owned by hedge funds and other institutional investors.

Global X Genomics & Biotechnology ETF Price Performance

GNOM opened at $9.43 on Thursday. The stock has a market capitalization of $65.73 million, a price-to-earnings ratio of -4.03 and a beta of 1.03. The business has a fifty day moving average price of $9.90 and a 200 day moving average price of $10.52. Global X Genomics & Biotechnology ETF has a 12 month low of $9.29 and a 12 month high of $12.53.

Global X Genomics & Biotechnology ETF Profile

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research.